Results 241 to 250 of about 140,561 (343)
Prognostic Value of Pathological Response After Conversion Therapy and Salvage Surgery in Unresectable Hepatocellular Carcinoma. [PDF]
Chi QY +9 more
europepmc +1 more source
A new nanoparticle‐based biomarker panel is described that can differentiate pancreatic cancer from benign pancreatic disease with a high level of performance. This was enabled by microelectrode array recovery technology that used dielectrophoresis (DEP) to quickly and efficiently recover the nanoparticles from patient plasma samples, followed by on ...
Anna Malakian +23 more
wiley +1 more source
Induction of endogenous tumor necrosis factor in hepatocellular carcinoma.
Yoshihiro FUKUDA +9 more
openaire +2 more sources
Growth differentiation factor 11 reprograms M2-like macrophages: Targeting immunometabolism for cancer therapy. [PDF]
Mohammadi S, Darweesh M, Al-Harrasi A.
europepmc +1 more source
ABSTRACT Bisphenol A (BPA), its structural analogs, and phthalates are synthetic chemicals widely used, with documented endocrine‐disrupting activity. This study aimed to develop and validate a selective multiresidue analytical method for the simultaneous determination of BPA, 10 bisphenol analogs, and six phthalates in PET‐bottled mineral water.
Giulia Boito Reyes +3 more
wiley +1 more source
Animal models accurately representing acute liver failure (Review). [PDF]
Luo S +5 more
europepmc +1 more source
Abstract Background Hepatocellular carcinoma (HCC) is the most common canine hepatobiliary tumour. This study aimed to determine which criteria influenced outcome of HCC in a modern population of dogs across eight institutions. Methods The medical records of 106 dogs with HCC were retrospectively reviewed.
Emily A. Janik +2 more
wiley +1 more source
Hepatocellular Carcinoma Bridging and Downstaging: Advances in Locoregional Therapy. [PDF]
Fite EL +3 more
europepmc +1 more source

